When the F.D.A. approved the drug Aduhelm, the first Alzheimer’s treatment to receive the agency’s endorsement in almost two decades, it gave hope to many.
But the decision was contentious; some experts say there’s not enough evidence that the treatment can address cognitive symptoms.
What is the story behind this new drug?
Guest: Pam Belluck, a health and ... Show More
Yesterday
The Autism Diagnosis Problem
<p>Once primarily limited to severely disabled people, autism began to be viewed as a spectrum that included children and adults far less impaired. Along the way, the disorder also became an identity, embraced by college graduates and even by some of the world’s most successful p ... Show More
32m 40s
Nov 23
Sunday Special: Wicked, Good?
<p>“Wicked” was one of the biggest movies of 2024. It was culturally ubiquitous, a box office smash and an Oscar nominee for Best Picture. Now, a year later, “Wicked: For Good” arrives in theaters to finish the tale of the complicated friendship between Glinda the Good Witch and ... Show More
51m 44s
Nov 2021
Why Aduhelm, a new Alzheimer's treatment, isn't reaching many patients
Aduhelm, known generically as aducanumab, is the first drug to actually affect the underlying disease process associated with Alzheimer's. Yet sales have been limited, and the drug is reaching very few patients — at least so far. It's expensive, risky and likely doing little to i ... Show More
9m 45s